The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis-Reference-Cited by-同舟云学术

The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis

Published:2017-07 Issue:1 Volume:72 Page:14-19
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Löppenberg Björn,Dalela Deepansh,Karabon Patrick,Sood Akshay,Sammon Jesse D.,Meyer Christian P.,Sun Maxine,Noldus Joachim,Peabody James O.,Trinh Quoc-Dien,Menon Mani,Abdollah Firas

Publisher

Elsevier BV

Subject

Urology

Reference24 articles.

1. American Cancer Society. Cancer facts and figures 2015. Atlanta, GA: American Cancer Society; 2015.

2. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer;Heidenreich;Eur Urol,2014

3. Treating patients with metastatic castration resistant prostate cancer: A comprehensive review of available therapies;Crawford;J Urol,2015

4. Drug costs in the management of metastatic castration-resistant prostate cancer in Canada;Dragomir;BMC Health Serv Res,2014

5. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer;Flanigan;N Engl J Med,2001

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations on the treatment of metastatic hormone-sensitive prostate cancer: Patient selection;Actas Urológicas Españolas (English Edition);2024-05

2. Recomendaciones de tratamiento en el cáncer de próstata hormonosensible metastásico: selección de pacientes;Actas Urológicas Españolas;2024-04

3. Biochemical outcome in metastatic prostate cancer patients following prostate-directed radiotherapy;ecancermedicalscience;2024-03-26

4. Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancer;Cancer/Radiothérapie;2024-02

5. Prognostic nomogram model for selecting between transarterial chemoembolization plus lenvatinib, with and without PD-1 inhibitor in unresectable hepatocellular carcinoma;British Journal of Radiology;2024-01-25